Gordon J. Fehr

Gordon J. Fehr is a declared insider of Merrimack Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 10 filings cover trades dated from 3 April 2012 to 13 April 2015.

Market trades split into 1 purchase (€7,558) and 2 sales (€315k). On balance, insiders were net sellers of €308k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 option exercises. So far in 2015, the count stands at no purchases and 1 sale.

The newest entry dates from 15 April 2015: an option exercise of €32k, in Merrimack Pharmaceuticals Inc. The most recent open-market purchase was published on 5 April 2012, 5,331 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.